Wire Stories
CANbridge Pharmaceuticals Receives Chinese Marketing Approval for Hunterase� First Enzyme Replacement Therapy for Hunter Syndrome in China
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted cancers, announced...